Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beijing Tiantan MMR Vaccine Schedule Comparison
NCT03160820Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of M-M-R II in measles, mumps, rubella, sponsored by Centers for Disease Control and Prevention. Started Mar 2016; status: completed.
02
Drugs
M-M-R II
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT03160820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160820.